Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils - Wikidata - awgldk - TriplyDB

Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils

Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils

http://www.wikidata.org/entity/Q33788110

about

High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis Neutrophil enhancement of Pseudomonas aeruginosa biofilm development: human F-actin and DNA as targets for therapy Material properties of biofilms-a review of methods for understanding permeability and mechanics The formation of biofilms by Pseudomonas aeruginosa: a review of the natural and synthetic compounds interfering with control mechanisms Future perspective on host-pathogen interactions during bacterial biofilm formation within the nasopharynx Activity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosis ChIP-Seq and RNA-Seq reveal an AmrZ-mediated mechanism for cyclic di-GMP synthesis and biofilm development by Pseudomonas aeruginosa Characterization of mucosal Candida albicans biofilms A Lipid Mediator Hepoxilin A3 Is a Natural Inducer of Neutrophil Extracellular Traps in Human Neutrophils Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis.Advances in microbial biofilm prevention on indwelling medical devices with emphasis on usage of acoustic energy Interaction of Candida albicans with adherent human peripheral blood mononuclear cells increases C. albicans biofilm formation and results in differential expression of pro- and anti-inflammatory cytokines.Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis.Pathogenesis of mucosal biofilm infections: challenges and progress.Gene expression profile and pathogenicity of biofilm-forming Prevotella intermedia strain 17 Polyelectrolyte properties of filamentous biopolymers and their consequences in biological fluids.Antimicrobial Efficacy of Contact Lens Care Solutions Against Neutrophil-Enhanced Bacterial Biofilms.Neutrophil extracellular trap (NET)-mediated killing of Pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR.Pseudomonas aeruginosa infectious keratitis in a high oxygen transmissible rigid contact lens rabbit model Interactions between polymorphonuclear leukocytes and Pseudomonas aeruginosa biofilms on silicone implants in vivo Estrogen aggravates inflammation in Pseudomonas aeruginosa pneumonia in cystic fibrosis mice.Neutrophil extracellular traps and bacterial biofilms in middle ear effusion of children with recurrent acute otitis media--a potential treatment target Enhanced in vitro formation and antibiotic resistance of nonattached Pseudomonas aeruginosa aggregates through incorporation of neutrophil products.Mycobacterium abscessus induces a limited pattern of neutrophil activation that promotes pathogen survival.Medical biofilms.Bacterial neuraminidase facilitates mucosal infection by participating in biofilm production Disruption of contact lens-associated Pseudomonas aeruginosa biofilms formed in the presence of neutrophils.Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo.Expression of antimicrobial drug tolerance by attached communities of Mycobacterium tuberculosis.Cryptococcus neoformans cells in biofilms are less susceptible than planktonic cells to antimicrobial molecules produced by the innate immune system.Polyelectrolyte-mediated increase of biofilm mass formation.Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization.Bactericidal activities of cathelicidin LL-37 and select cationic lipids against the hypervirulent Pseudomonas aeruginosa strain LESB58.Host-pathogen interplay in the respiratory environment of cystic fibrosis.Amyloid-DNA Composites of Bacterial Biofilms Stimulate Autoimmunity In Vivo Efficacy of Antimicrobials against Biofilm-Producing Pseudomonas aeruginosa.Increased therapeutic efficacy of combination of azithromycin and ceftazidime on Pseudomonas aeruginosa biofilm in an animal model of ureteral stent infection Deciphering mechanisms of staphylococcal biofilm evasion of host immunity.The exopolysaccharide Psl-eDNA interaction enables the formation of a biofilm skeleton in Pseudomonas aeruginosa.Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway

P2860

Q24545304-810ECF32-EA24-401C-A35D-DB7335FBECE1 Q24650612-00B25659-18EE-4773-9B15-19B4B54FF5E2 Q26825802-6879F3FE-646C-4E22-BF68-314D8F8ABCE5 Q26849416-4DD47F7B-7D0D-410A-A33E-90F024088328 Q26863174-A953A070-AA3B-4188-8701-049278E291A8 Q28475562-4A0B9BEB-6438-49F6-8F84-D06355BCAA47 Q28492571-B3800826-8C96-42A9-8D13-C2535BF30B39 Q28750198-87FE4EAE-B200-4C57-A433-35E149164DDC Q29013771-3724AC06-005D-4D0F-9C2C-D3E2A0B83289 Q30425441-996F792C-A23A-443A-9524-B2A649E4D248 Q30467753-B35778D4-0252-48F6-A268-02953EA439EA Q30479433-B5053F49-C0ED-45D1-B764-0F2FB1C24C9A Q33298018-0C808A67-8AB5-4412-9219-284F7AF1A44B Q33326460-040E5391-1AE3-443F-90A2-92C6E9760329 Q33400139-46F8E5EC-C67D-4892-A8FB-119F0D5F8756 Q33563964-4B88040F-3B1D-4BB6-BE7D-2109FAEA4F7A Q33626325-4D83917E-122B-42FE-9CB5-5BBFF08E5B96 Q34016539-671E8093-AED9-4291-86E6-D9D1BF9AAC07 Q34211398-701DB65B-D48E-493E-BE50-FE3F6CC4A406 Q34268901-BFBAB962-FC27-482F-B3B2-59C3225622DE Q34426614-3629C0C3-877C-4CFA-8BF0-EB8E14F3BB0B Q34580853-82D6C925-4886-49C8-83FB-B1E0AA6A0DFD Q34596738-10849CDE-643A-4E23-A79A-4CCEECAA2932 Q34603485-C343E196-A1E8-4226-9852-0B0F7290B352 Q34764576-A70F3538-4C80-42F6-B435-89814CE6DC57 Q34803233-ED60703F-686D-4D0A-9702-0931F94F2FEE Q34937175-0DAE6567-4043-44AF-956E-1CB676F2EF63 Q35033196-C1D472BC-53D3-4680-82D2-D6DB03949DD7 Q35180731-3BDD101C-FFD0-4426-A8E2-FF164C30E3DC Q35217511-A3EC3A28-A1D3-4C37-8991-7C334DEEFDD4 Q35654991-C3501889-E7C7-4912-A160-C584958BDED7 Q35738790-BFB022CA-EE4E-48B5-8014-82F4EF25FDE6 Q35746038-E7C1118A-811E-44E9-9741-81342E0C9B8B Q35799736-6F40C0CF-9719-480E-AFF8-1B6BE23E2BF1 Q35845485-47A49F15-6BAD-48DA-8D96-381BA2FE8014 Q35859891-26E0EFF5-0493-4621-9039-DDDE2BE1F590 Q36061216-DDD79822-4D9C-4BD2-9442-40EE464D8780 Q36158847-BDF42668-5027-43C3-A42C-B2A663231A48 Q36307388-094D7707-AE30-4A76-B339-69468E27B045 Q36889877-BB874875-A4C8-41B7-854B-0C9AB5F98EE9

P2860

Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils

http://www.wikidata.org/entity/Q33788110

description

2005 nî lūn-bûn

@nan

2005 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils

@ast

Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils

@en

type

label

Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils

@ast

Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils

@en

prefLabel

Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils

@ast

Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils

@en

P1433

Q33788110-ED395040-9CA7-45A5-89E6-1410B58AF241

P1476

Q33788110-C860C63D-26E4-4F71-AE43-B2A8B78FF54C

P2093

Q33788110-2262EBEE-5B75-40C8-A8A5-D06D94F36ED7

Q33788110-63A878DB-4D73-4583-89C9-20394D2C2949

Q33788110-65D7DC78-06A7-48C2-9728-C8E744FF701D

Q33788110-8F4734C1-A64B-4D10-B26E-7A4F2950A4EA

Q33788110-B88AE217-8F2B-4001-96BC-E9C389D70815

Q33788110-C683D3BE-178E-47A7-89AC-36C42D95345F

Q33788110-E8D49857-8675-424B-A6D4-98CAEF574105

Q33788110-F4ED1DDC-BA68-4B5B-B60C-04853E286508

Q33788110-F61CC3A8-ABE5-47B8-AE1A-AEB2FE88D382

Q33788110-FAD68C55-CC30-4DB2-BDDB-4014E28EA5E6

P2860

Q33788110-0C485CBC-ECC0-4C68-A57F-BCB241D653F6

Q33788110-1D1CBC5F-E9C8-4AC5-83E2-86639D22EBA8

Q33788110-1F58CC34-E395-4F79-BF79-481B18092CF8

Q33788110-21BE3EFE-420E-4052-9F8C-CED56D84945B

Q33788110-27F6F934-DF3E-4CAE-80F6-543F11B59B34

Q33788110-2D763524-7A6D-444C-A25E-C22F40AD83AD

Q33788110-392EC249-5B84-463B-9125-7F9AC466519F

Q33788110-45FC3C23-B727-4232-9E9A-320B65A97804

Q33788110-48F7C968-FF01-4A56-B767-4491C6E1A65F

Q33788110-50AA3BCE-B32F-4888-997F-6B5A8C24588E

P304

Q33788110-C6A716C0-1C2B-4A33-B032-48FC0091BE9F

P31

Q33788110-1D86277D-0DC4-4E5D-8703-027D80C010AD

P356

Q33788110-CE297080-CE91-44ED-924B-05CEC31E8D42

P407

Q33788110-A6027A5C-C841-43EA-AF84-2988BD8D3D23

P433

Q33788110-F0B4673E-9FE4-4B9C-8433-5F33E9DD8C0E

P478

Q33788110-B1F5B581-DAA0-42AC-88C9-C604E27C26B6

P577

Q33788110-96ED33B8-EFA0-4AD2-B1EB-3CBB59B488AB

P698

Q33788110-C4DC7E45-BFCE-4F85-982C-C6FF46615ED1

P921

Q33788110-65FE911E-12CD-43EA-ACE3-833344BCD0EE

Q33788110-BBDE77D3-A4C3-40AF-A3CB-2CBEF905EE98

P932

Q33788110-31A33F7E-74A9-46B7-85CA-48FEAC10D69C

P356

IAI.73.6.3693-3701.2005

P1433

Infection and Immunity

P1476

Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils

@en

P2093

G Scott Worthen

http://www.w3.org/2001/XMLSchema#string

Jerry A Nick

http://www.w3.org/2001/XMLSchema#string

Jonathan G Lieber

http://www.w3.org/2001/XMLSchema#string

Katie R Poch

http://www.w3.org/2001/XMLSchema#string

Kenneth C Malcolm

http://www.w3.org/2001/XMLSchema#string

Kerry L Tomlin

http://www.w3.org/2001/XMLSchema#string

Michael B Fessler

http://www.w3.org/2001/XMLSchema#string

Michael L Vasil

http://www.w3.org/2001/XMLSchema#string

Milene T Saavedra

http://www.w3.org/2001/XMLSchema#string

Travis S Walker

http://www.w3.org/2001/XMLSchema#string

P2860

Extracellular DNA Required for Bacterial Biofilm Formation

A component of innate immunity prevents bacterial biofilm development

Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients

Neutrophil extracellular traps kill bacteria

Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa

Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms

Role of the vegetation in experimental Streptococcus viridans endocarditis.

Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis.

Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants.

Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype.

P304

3693-3701

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.73.6.3693-3701.2005

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

2005-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15908399

http://www.w3.org/2001/XMLSchema#string

P921

Pseudomonas aeruginosa

P932

1111839

http://www.w3.org/2001/XMLSchema#string